SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and break below key support levels are dominating discussion, with traders pointing to leveraged-long liquidations and broader risk-off pressure across crypto and tech as possible contributors. The community is split between warnings of further downside and calls to buy an oversold dip or watch for support.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas reiterated that topline results from its Phase 3 REGAL trial of GPS in AML are expected in November after the trial reached its required event milestone, drawing attention to the pending binary readout. Traders are broadly excited about the prospect of positive data and a short squeeze, while speculation about a leak or buyout remains unconfirmed and skeptics stress that results have not been released and the trial outcome is uncertain.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints about work interruptions and concern that the prolonged disruption could damage trust or pressure the stock. Some traders speculated about a cyberattack, but the cause was not confirmed, and others questioned why shares held relatively steady.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline toward the $1 support level amid a broader crypto selloff is dominating discussion, with traders pointing to Bitcoin weakness, inflation and rate concerns, and liquidations. Bears warn of further downside and question Ripples ability to provide catalysts, while some holders view the drop as a buying opportunity and continue accumulating.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Weakness in Ethereum and broader crypto-linked stocks is weighing on BitMine, while traders also criticize its underperformance and question managements spending, transparency, and buybacks. Some see the stocks discount to its crypto holdings as a buying opportunity, but bearish posts argue falling ETH prices can overwhelm any support from repurchases.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure as Bitcoin and broader crypto markets sell off, with traders highlighting COINs repeated new lows and weak performance even when Bitcoin stabilizes. Bearish calls dominate, though some see the decline as oversold and are buying the dip.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Metropolis Healthcare introduces advanced blood-based Alzheimer’s screening

… Surendran Chemmenkotil, Managing Director, Metropolis Healthcare said: “As India’s … Scientific and Innovation Officer, Metropolis Healthcare said: “In Alzheimer’s … outcomes. This launch reinforces Metropolis Healthcare ’s commitment to advancing …

Brain health startup Ivory develops 'treadmill test' for brain; focusses on cognitive health in India

The AI-powered startup offers cognitive assessments measuring attention, memory, and executive function, providing users with benchmarked scores and actionable insights. The company aims to embed cognitive testing across healthcare touchpoints, helping clinicians distinguish early cognitive decline from lifestyle-driven issues through more objective, data-driven tools. It has partnered with Metropolis Healthcare and is in talks with diagnostic chains, insurers, and wellness platforms, including Ultrahuman.

Dividend, bonus issue alert: Midhani among 7 stocks turning ex-date for corporate actions this week

Stocks likely to be in focus include DIC India, 5Paisa Capital, Banco Products (India), Falcon Technoprojects India, Mishra Dhatu Nigam (Midhani), Maha Rashtra Apex Corporation and Metropolis Healthcare

Business News | Metropolis Healthcare's Centre of Genomics Hosts Multi-Specialty Genomics Symposium to Accelerate Precision Medicine in India

… Promoter and Executive Chairperson, Metropolis Healthcare Limited, said, "The … led drug development. About Metropolis Healthcare Limited Established in 1981, Metropolis … class diagnostic services to patients, healthcare providers, and corporates across …

Metropolis Healthcare’s Centre of Genomics Hosts Multi-Specialty Genomics Symposium to Accelerate Precision Medicine in India

Mumbai (Maharashtra) [India], February 14: Ameera Shah-led Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650), India's second largest and the most trusted pathology laboratory chain, hosted a high-impact Scientific Symposium on Genomics, bringing together over 300 clinicians, researchers, scientists and academicians to advance the clinical integration of genomic diagnostics across India's healthcare ecosystem.

Is India’s healthcare sector ready for execution in 2026?

… expansion. Beyond drug manufacturing, healthcare delivery also saw visible change … and Executive Chairperson of Metropolis Healthcare . Hospitals, diagnostics chains, digital … in improving use of existing healthcare infrastructure, provided training and …

Metropolis Healthcare unveils scientifically curated GLP-1 monitoring test packages to support safe metabolic care in India

Metropolis Healthcare has launched three specialised metabolic … . Surendran Chemmenkotil, managing director, Metropolis Healthcare Limited, said: “As GLP-1 … Scientific and Innovation Officer, Metropolis Healthcare Limited, said: “Developing meaningful GLP …

Metropolis Healthcare launches scientifically curated GLP-1 monitoring test packages

Metropolis Healthcare , India’s second-largest and … , Surendran Chemmenkotil, Managing Director, Metropolis Healthcare Limited, said: “As GLP-1 … Scientific and Innovation Officer, Metropolis Healthcare Limited, said: “Developing meaningful GLP …

Nathealth calls for urgent action in 2026-27 Union Budget to increase healthcare public spend to over 2.5% of GDP

… outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand … Nathealth & executive chairperson, Metropolis Healthcare , said, “For India to realise … and frontier innovation. India’s healthcare providers have already proven their …

India Needs a big healthcare push in Union Budget 2026–27, says NATHEALTH as NCD burden soars

… two per cent to global healthcare expenditure. NATHEALTH’s budget … NATHEALTH and Executive Chairperson, Metropolis Healthcare Ltd, said, “For India to … emphasises that strategic investments in healthcare deliver multiplier effects for employment …

Metropolis Healthcare Ltd. engages in the provision of medical laboratories. It operates through the India and Outside India geographical segments. It offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, hematology, and immunochemistry. The company was founded by Sushil Kanubhai Shah and Gomathi Babu Sadacharam Kulandai Velu in 1981 and is headquartered in Mumbai, India.

Metropolis Healthcare Ltd.

Healthcare Stocks Get A GST Boost: Index Nears Breakout; Bull Run Likely In Apollo, Fortis, Dr Lal, Poly Medicure 

Equity

Neutral Sentiment

India’s healthcare sector has received a boost from the latest round of Goods and Services Tax (GST) reform.The government has lowered GST across several products and services in the healthcare basket, making treatments and coverage more affordable while creating volume opportunities for companies.What Got CheaperHealth and life insurance, previously taxed at 18%, will now attract no GST at all. Thermometers have been reduced from 18% to 5%. Medical-grade oxygen, diagnostic kits, reagents, glucometers, and test strips have all seen rates cut from 12% to 5%.&nbsp;Corrective spectacles also shift from 12% to 5%. Finkhoz said these cuts translate into lower costs for consumers and stronger demand across healthcare services and products.Technical ViewSEBI-registered platform&nbsp;<a href="https://stocktwits.com/Finkhoz">Finkhoz</a> said the Nifty Healthcare index is consolidating just below the key resistance zone of 14,800–15,000, noting that the index is forming an inverted head-and-shoulders pattern, with the neckline around the same zone.&nbsp;<stembedurl>https://stocktwits.com/Finkhoz/message/628102110</stembedurl>A breakout above 14,800–15,000, if supported by volume, could trigger a rally toward 15,800–16,200, while strong support is placed at 14,000.Stocks To WatchPrivate hospitals, such as Apollo Hospitals and Fortis Healthcare, could see an increase in demand as wider insurance coverage makes it easier for patients to choose private care.&nbsp;Diagnostic players like Metropolis Healthcare and Dr Lal Pathlabs are also likely to benefit, with cheaper kits expected to drive more people toward regular testing and higher volumes.&nbsp;Medical device makers such as Poly Medicure are positioned to benefit from lower GST on devices and reagents. Optical businesses, including Titan Company’s Titan Eye+, may also see a lift from cheaper spectacles.&nbsp;Insurance players like HDFC Life, ICICI Prudential, and SBI Life could be major winners, with tax-free health insurance described by Finkhoz as a “game-changer.”Analyst ViewFinkhoz said the GST cuts are not only about affordability but also about broadening access to healthcare.&nbsp;More insurance adoption, cheaper diagnostics, and lower device costs are expected to create steady growth opportunities across healthcare and insurance. “For investors, healthcare just got its booster shot,” the analyst concluded.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The analyst said the GST cut expands access to care while opening steady opportunities for companies in the sector.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	2.88	--	--	N/A
Q2 '26	3.38	--	--	N/A
Q1 '26	2.68	--	--	N/A
Q4 '25	2.57	--	--	N/A
Q3 '25	8.77	--	--	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

METROPOLIS.NSE Earnings

Upcoming Earnings: Q3 '26

Historical Earnings